Molecular profiling after short-term preoperative endocrine therapy to identify oestrogen receptor positive (ER+)/HER2+ early breast tumours with favourable prognosis.

Abstract: 560 Poster Bd #: 152

Poster

Descargar

Autor
Milana Bergamino Sirvén, MD, PhD

Institute of Cancer Research

Compartir:

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON